Canakinumab for the Patient With Difficult-to-Treat Gouty Arthritis: Review of the Clinical Evidence

Abstract

Many patients with gouty arthritis experience frequent flares and have comorbidities that may limit their anti-inflammatory treatment options for acute flare management. For patients with contraindications to both NSAIDs and/or colchicine, treatment options are particularly limited, and there is an unmet medical need in this subgroup of patients.

להמשך קריאה »

Thomas Bardin, Canakinumab for the Patient With Difficult-to-Treat Gouty Arthritis: Review of the Clinical Evidence, Joint Bone Spine, Volume 82, Supplement 1, 2015, Pages eS9-eS16,
ISSN 1297-319X,
https://doi.org/10.1016/S1297-319X(15)30003-8.